U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915973) titled 'Impacto 2.0: Mobile Smoking Cessation Across Texas' on Oct. 26.
Brief Summary: This is a preliminary efficacy trial that will examine whether Impacto 2.0 produces higher rates of biochemically verified smoking abstinence among Hispanic adults across Texas compared to the NCI quitSTART app. The primary objective is to evaluate the preliminary efficacy of Impacto 2.0 in reducing smoking, tobacco withdrawal, and craving. One hundred Hispanic adults who smoke will be recruited across Texas and followed remotely over an 8-week intervention period with a 3-month post-quit follow-up.
Study Start Date: Feb. 01, 2027
Study Type: INTERVENTIO...